Navigation Links
Beckman Coulter Announces Third Quarter 2007 Results
Date:10/30/2007

2.3

Litigation settlement - - - (35.0)

Total operating costs

and expenses 244.4 260.3 727.9 701.3

Operating income 67.5 37.4 197.8 162.1

Non-operating (income)

expenses

Interest income (3.3) (3.2) (11.1) (10.9)

Interest expense 12.2 12.5 38.9 39.0

Other, net (19.7) 3.8 (58.4) 2.7

Total non-operating

(income) expenses (10.8) 13.1 (30.6) 30.8

Earnings from continuing

operations before income

taxes 78.3 24.3 228.4 131.3

Income taxes 19.9 6.6 63.5 35.4

Earnings from continuing

operations 58.4 17.7 164.9 95.9

Earnings from discontinued

operations, net of tax 1.6 29.7 1.6 28.7

Net earnings $60.0 $47.4 $166.5 $124.6

Basic earnings per share

Continuing operations $0.93 $0.28 $2.64 $1.53

Discontinued operations 0.03 0.48 0.03 0.46

Basic earnings per share $0.96 $0.76 $2.67 $1.99

Diluted earnings per share

Continuing operations $0.91 $0.28 $2.58 $1.50

Discontinued operations 0.02 0.46 0.03 0.45

Diluted earnings per

share $0.93 $0.74 $2.61 $1.95

Weighted average number of

shares outstanding

(in thousands):

Basic 62,889 62,427 62,379 62,636

Diluted 64,518 63,755
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... Corporation (Nasdaq: DNDN ) announced today that ... have exercised in full their option to purchase ... the public offering price of $24.75 per share. ... size of the offering to an aggregate of ... to receive net proceeds from the offering of ...
(Date:12/11/2009)... Dec. 11 Ambit Biosciences Corporation announced today ... M. D. Anderson Cancer Center of the first patient ... E fficacy) Phase 2 pivotal trial ... (AML). AC220 is a novel, orally available, potent ... as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ...
(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...
(Date:12/10/2009)... Dec. 10 Endologix, Inc. (Nasdaq: ... aortic disorders, announced today that Dan Lemaitre, former ... Endologix Board of Directors effective December 11, 2009. ... three non-independent directors. ,, Franklin D. Brown, Chairman ... welcome Dan Lemaitre to the Endologix Board of ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2
... is available in German . , ... , is able to rapidly ,and efficiently detoxify chemical ... the Tokyo subway attacks in 1995. A detailed understanding ... is ,necessary for efforts aiming to improve their properties. ...
... Inc. (Nasdaq: ANDS ) announced today that ... Thursday, April 23, 2009, after the U.S. financial markets ... Thursday, April 23, 2009 at 5:00 p.m. Eastern Daylight ... and highlights and to provide an update on its ...
... clinical development solutions in North America, Europe and ... ClinPharm (SIRO), a leading multinational Contract Research ... strategic alliance with Advanced Clinical Trial Solutions LLC ... in oncology drug development with a business concentration ...
Other Biology Technology:Structure of enzyme against chemical warfare agents determined 2Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results 2SIRO ClinPharm and Advanced Clinical Trial Solutions Ink Strategic Alliance 2
(Date:12/14/2009)... once thought of tool use as a defining feature of ... other primates, along with birds and an array of other ... Current Biology , a Cell Press publication, adds an ... veined octopus under study manages a behavioral trick that the ... itself over stacked, upright coconut shell "bowls," makes its eight ...
(Date:12/13/2009)... help to engineer plants that take advantage of elevated ... could help to engineer crops that take advantage of ... dioxide they need for photosynthesis through microscopic breathing pores ... of the gas gained, they lose hundreds of water ... to save water when CO 2 is abundant, ...
(Date:12/13/2009)... at The Scripps Research Institute have solved a ... an ancient family of enzymes can have two ... to providing guidance for understanding other molecules in ... for the protein,s possible use for combating diseases ... was published in the December 13, 2009 advance, ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Acetaminophen May Weaken Effectiveness of Kids Vaccines 59592 1Acetaminophen May Weaken Effectiveness of Kids Vaccines 59592 2Dr Julian Whitaker Pens Forward for Suzanne Somers 26apos 3B New Cancer Book 59588 1Dr Julian Whitaker Pens Forward for Suzanne Somers 26apos 3B New Cancer Book 59588 2LifeCare Hospitals Appoints New Executive Vice President of Operations 59584 1
... of seashells 15 years ago, Dr. Gary Rosenberg did ... light on a 40-year-old evolutionary debate. , The debate ... animals isolated on islands evolve to be larger than ... smaller. In a paper to be published in September ...
... virus called GB Virus type C (GBV-C) protects against HIV ... Veterans Affairs (VA) Iowa City Health Care System and the ... inhibits HIV from growing in cell models. , The team ... protein called NS5A greatly slows down HIV from replicating in ...
... look at the battlefield on which plant diseases are ... of Sheng Yang He at Michigan State University has ... and is unveiling new knowledge of how bacterial pathogens ... published in the Sept. 8 edition of Cell, redefines ...
Other Biology News:Scientist's persistence sheds light on marine science riddle 2Study IDs protein that inhibits HIV from growing in cell cultures 2Study IDs protein that inhibits HIV from growing in cell cultures 3Plants give up answers in the war on bacteria 2
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Phospho-CD18 (Ser756/Thr758/759) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
Biology Products: